Alkermes Announce Completion Of Merger Between Alkermes And Elan Drug Tech

Alkermes and Elan Corporation announced the completion of the merger between Alkermes and Elan Drug Technologies , the drug formulation and manufacturing business unit of Elan. The businesses were combined under a newly-formed company, Alkermes, which is incorporated in Ireland and headquartered in Dublin.

Under the terms of the business combination agreement, Elan Corporation receives $500 million in cash and 31.9 million ordinary shares of Alkermes, representing approximately 25% of Alkermes. Based on the closing share price of Alkermes on September 15, 2011 of $16.52, this represents a total transaction value of approximately $1.0 billion.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.